A detailed history of Marshall Wace, LLP transactions in Olink Holding Ab (Publ) stock. As of the latest transaction made, Marshall Wace, LLP holds 558,569 shares of OLK stock, worth $0. This represents 0.02% of its overall portfolio holdings.

Number of Shares
558,569
Previous 551,049 1.36%
Holding current value
$0
Previous $13 Million 9.86%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$21.87 - $25.59 $164,462 - $192,436
7,520 Added 1.36%
558,569 $14.2 Million
Q1 2024

May 15, 2024

BUY
$21.81 - $25.14 $10.3 Million - $11.8 Million
470,049 Added 580.31%
551,049 $13 Million
Q4 2023

Feb 14, 2024

BUY
$14.29 - $25.95 $1.16 Million - $2.1 Million
81,000 New
81,000 $2.04 Million
Q4 2021

Feb 14, 2022

SELL
$18.0 - $34.82 $212,598 - $411,259
-11,811 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$23.42 - $37.93 $276,613 - $447,991
11,811 New
11,811 $287,000

Others Institutions Holding OLK

About Olink Holding AB (publ)


  • Ticker OLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 119,098,000
  • Description
  • Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...
More about OLK
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.